Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.13.5305

Do Leukocyte and Platelet Counts Have Benefit for ＼Preoperative Evaluation of Endometrial Cancer?  

Ekici, Huseyin (Kackar State Hospital)
Malatyalioglu, Erdal (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
Kokcu, Arif (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
Kurtoglu, Emel (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
Tosun, Migraci (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
Celik, Handan (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.13, 2015 , pp. 5305-5310 More about this Journal
Abstract
Purpose: The aim of this study was to investigate the association between preoperative leukocyte and platelet counts and the stage of the disease in patients with endometrial cancer. Materials and Methods: Data for 100 patients undergoing total abdominal hysterectomy and bilateral salpingoophorectomy for benign uterine diseases and 177 patients surgically staged for endometrial cancer at Ondokuz Mayis University, Department of Gynecology and Obstetrics between 2005 and 2013, with preoperative complete blood count in the week prior to surgery including WBC, platelet count, pathologic evaluation for both benign and malign endometrium lesions, tumor stage and presence of lymphovascular space invasion (LVI), were retrospectively analyzed. Results: The preoperative leukocyte count was significantly higher in patients with endometrial cancer when compared to the patients with benign diseases. However, there were no significant differences in platelet counts between the groups. Patients with advanced stage endometrial cancer had higher preoperative leukocyte counts when compared to the early stage disease whereas there was no difference in platelet count. Multivariate regression analysis identified preoperative leukocytosis as an independent prognostic factor for endometrial cancer. The optimal cut-off point for WBC was calculated as 10,500 to differentiate stage 1-2-3 and 4 with 88.9% sensitivity and 86.3% specificity (AUC: 0.901, 95% CI: 0.829-0.973, p<0.001, PPV: 25.8%, NPV: 99.3%). Conclusions: Preoperative leukocytosis is independently associated with advanced endometrial cancer.
Keywords
Endometrial cancer; leukocytosis; prognosis; stage; thrombocytosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Acmaz G, Aksoy H, Unal D, et al (2014). Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev, 15, 1689-92.   DOI
2 Amant F, Moerman P, Neven P, et al (2005). Endometrial cancer. Lancet, 366, 491-505.   DOI
3 Ayhan A, Bozdag G, Taskiran C, et al (2006). The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Gynecol Oncol, 103, 902-5.   DOI   ScienceOn
4 Blay JY, Negrier S, Combaret V, et al. (1992). Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res, 15, 3317-22.
5 Brockmann MA, Giese A, Mueller K, et al (2007). Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol, 9, 335-42   DOI
6 Burstein SA, Harker LA. (1983). Control of platelet production. Clin Haemato, 12, 3-22.
7 Chen YM, Whang-Peng J, Liu JM, et al. (1995). Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis. Jpn J Clin Onco, 25, 168-72.
8 Chen CC, Yang CF, Yang MH, et al (2005). Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia. Ann Oncol, 16, 1366-73.   DOI
9 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al (2012). GLOBOCAN Cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet]. Lyon, France: International Agency Res Cancer, 2013.
10 Garcia-Arias A, Cetina L, Candelaria M, Robles E, Duenas Gonzalez A. (2007). The prognostic significance of leukocytosis in cervical cancer. Int J Gynecol Cancer, 17, 465-70.   DOI
11 Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O. (2009). Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer, 19, 1384-9   DOI
12 Gucer F, Moser F, Tamussino K, et al. (1998). Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol, 70, 210-4.   DOI
13 Hefler L, Mayerhofer K, Leibman B, et al (2000). Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol, 21, 309-14.   DOI
14 Heng S, Benjapibal M. (2014). Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev, 15, 10231-6.
15 Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J (1992). Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer, 69, 2975-7.   DOI
16 Luomaranta A, Leminen A, Loukovaara M. (2013). Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol, 129, 28-32.   DOI
17 Karpatkin S, Pearlstein E. (1981). Role of platelets in tumor cell metastases. Ann Intern Med, 95, 636-41.   DOI
18 Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ (2007). The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol, 104, 91-4.   DOI
19 Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ. (2007). Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol, 43, 283-8.   DOI
20 Mabuchi S, Matsumoto Y, Isohashi F, et al (2011). Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol, 122, 25-32.   DOI
21 Metindir J, Bilir Dilek G. (2009). Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol, 135, 125-9.   DOI
22 Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol, 131, 410-5.   DOI
23 Pecorelli S (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet, 105, 103-4.   DOI
24 Pedersen LM, Milman N (2003). Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep, 10:213-6.
25 Sierko E, Wojtukiewicz MZ (2004). Platelets and angiogenesis in malignancy. Semin Thromb Hemost, 30, 95-108.   DOI
26 Prat J (2004). Prognostic parameters of endometrial carcinoma. Hum Pathol, 35, 649-62.   DOI
27 Sato K, Fujii Y, Ono M, Nomura H, Shizume K (1987). Production of interleukin 1 alpha-like factor and colonystimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis. Cancer Res, 15, 6474-80.
28 Scholz HS, Petru E, Gucer F, et al (2000). Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res, 20, 3983-5.
29 So KA, Hong JH, Jin HM, et al (2014). The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study. Gynecol Oncol, 132, 551-5.   DOI
30 Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40.   DOI
31 Verheul HM, Pinedo HM. (1998). Tumor Growth: a putative role for platelets? Oncologist, 3, 2.
32 Watanabe M, Ono K, Ozeki Y, et al. (1998). Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol, 28, 559-62.   DOI
33 Weiss G, Goodnough LT. (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23.   DOI
34 Worley MJ Jr, Nitschmann CC, Shoni M, et al (2012). The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol, 125, 561-5.   DOI